APPROPRIATE APIXABAN PROPHYLAXIS IN ONCOLOGY PATIENTS TO EVALUATE REDUCTION IN ADVERSE THROMBOEMBOLIC EVENTS

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations and/or diagnostic imaging agents for human use